Researchers at the Else Kröner Fresenius Center (EKFZ) for Digital Health at TUD Dresden University of Technology, in collaboration with partners from Germany, the U.K. and U.S., have developed and validated an autonomous artificial intelligence (AI) agent capable of supporting clinical decision-making in oncology.
Autonomous AI agent can support clinical decisions in oncology
